These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15356014)

  • 1. Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.
    Temelkova-Kurktschiev T; Hanefeld M; Chinetti G; Zawadzki C; Haulon S; Kubaszek A; Koehler C; Leonhardt W; Staels B; Laakso M
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4238-42. PubMed ID: 15356014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.
    Stumvoll M; Stefan N; Fritsche A; Madaus A; Tschritter O; Koch M; Machicao F; Häring H
    J Mol Med (Berl); 2002 Jan; 80(1):33-8. PubMed ID: 11862322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
    Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY
    J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymorphism of pro12Ala in peroxisome proliferator activated receptor gamma 2 (PPAgamma2): beta cell function and insulin sensitivity].
    Fritsche A; Madaus A; Tschritter O; Ozeker M; Wulle EL; Machicao F; Häring H; Stumvoll M
    Dtsch Med Wochenschr; 2001 May; 126(20):580-4. PubMed ID: 11402923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)gamma-2 with longevity.
    Barbieri M; Bonafè M; Rizzo MR; Ragno E; Olivieri F; Marchegiani F; Franceschi C; Paolisso G
    Exp Gerontol; 2004 Jul; 39(7):1095-100. PubMed ID: 15236769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese.
    Iwata E; Yamamoto I; Motomura T; Tsubakimori S; Nohnen S; Ohmoto M; Igarashi T; Azuma J
    Diabetes Res Clin Pract; 2003 Oct; 62(1):55-9. PubMed ID: 14581158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
    Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.
    Lee BC; Lee HJ; Chung JH
    Neurosci Lett; 2006 Dec; 410(2):141-5. PubMed ID: 17084528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.
    Ek J; Andersen G; Urhammer SA; Hansen L; Carstensen B; Borch-Johnsen K; Drivsholm T; Berglund L; Hansen T; Lithell H; Pedersen O
    Diabetologia; 2001 Sep; 44(9):1170-6. PubMed ID: 11596673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men.
    Rosmond R; Chagnon M; Bouchard C
    Diabetes Metab Res Rev; 2003; 19(2):159-63. PubMed ID: 12673785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Renn W; Häring HU
    Diabetologia; 1999 Jun; 42(6):758-62. PubMed ID: 10382597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus.
    Mazza A; Motti C; Nulli A; Marra G; Gnasso A; Pastore A; Federici G; Cortese C
    Metabolism; 2000 Jun; 49(6):718-23. PubMed ID: 10877195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
    Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
    Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPARgamma2.
    Thamer C; Haap M; Volk A; Maerker E; Becker R; Bachmann O; Machicao F; Häring HU; Stumvoll M
    Horm Metab Res; 2002 Mar; 34(3):132-6. PubMed ID: 11972302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peroxisome proliferator-activated receptor gamma C-161T polymorphism and carotid artery atherosclerosis in metabolic syndrome].
    Yan ZC; Zhu ZM; Shen CY; Zhao ZG; Ni YX; Zhong J; Nie H
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):543-7. PubMed ID: 15144586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    Caramori ML; Canani LH; Costa LA; Gross JL
    Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic consequences of the peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism: the weight of the evidence in genetic association studies.
    Florez JC
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4234-7. PubMed ID: 15356013
    [No Abstract]   [Full Text] [Related]  

  • 19. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
    Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
    Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pro 12 Ala substitution in the PPARγ2 polymorphism may decrease the number of diseased vessels and the severity of angiographic coronary artery.
    Youssef SM; Mohamed N; Afef S; Khaldoun BH; Fadoua N; Fadhel NM; Naceur SM
    Coron Artery Dis; 2013 Aug; 24(5):347-51. PubMed ID: 23652363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.